Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 4, 2011, Pages 479-484

  Hossain, Noreen ^a,b   Stepanova, Maria ^a   Afendy, Arian ^a,b   Nader, Fatema ^a,b   Younossi, Youssef ^a   Rafiq, Nila ^a,b   Goodman, Zachary ^b   Younossi, Zobair M ^a,b  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

NAFLD; NASH; PCOS

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CHOLESTEROL, HDL; FATTY LIVER; FEMALE; HUMANS; LIVER; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYCYSTIC OVARY SYNDROME; PREVALENCE;

EID: 79952614750     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.539251     Document Type: Article

References (29)

1. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158-61.
2. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008;28:386-95.
3. Ong IP, Pitts A, Younossi ZM. Increased mortality and liver-related mortality in patients with nonalcoholic fatty liver disease. J Hepatol 2008;49:608-12.
4. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27-41.
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. J Am Med Assoc 2002;287:356-9.
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.
7. Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region. Gastroenterol Hepatol 2007;22:775-7.
8. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28: 339-50.
9. Collantes RS, Ong JP, Younossi ZM. The metabolic syndrome and nonalcoholic fatty liver disease. Panminerva Medica 2006;48:41-8.
10. Nugent C, Younossi ZM. Evaluation and management of obesity-related non-alcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2007;14:432-41.
11. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002;35: 746-52.
12. Falck-Ytter Y, Younossi ZM, Marchesini G,McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.
13. Bondini S, Kleiner DE, Goodman Z, Gramlich T, Younossi ZM. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis 2007;11:17-23.
14. Kim CH, Younossi ZM. Non-alcoholic fatty liver disease. Cleveland Clinic J Med 2008;75:673-80.
15. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16.
16. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-15.
17. Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin Liver Dis 2009;13:249-66.
18. Kandaraki E, Chirstakou C, Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome. . . and vice versa. Arq Bras Endocrinol Metabol 2009;53: 227-37.
19. Ramos R, Olden K. The prevalence of metabolic syndrome among US women of child bearing age. Am J Public Health 2008;98:1122-7.
20. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007;4(Suppl B): S162-77.
21. Angioni S, Portoghese E, Milano F, Melis GB, Fulghesu AM. Diagnosis of metabolic disorders in women with polycystic ovary syndrome. Obstet Gynecol Survey 2008;63:796-802.
22. Brzozowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Hepatology 2009;24:243-7.
23. Mason H, Colao A, Blume-Peytavi U, Rice S, Qureshi A, Pellatt L, et al. Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review. Clin Endocrinol 2008;69: 831-44.
24. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1741-7.
25. Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007;47:412-17.
26. Zheng RH, Ding CF. Prevalence of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome: a case- control study. Zhonghua Fu Chan Ke Za Zhi 2008;43: 98-101.
27. Gambarin-Gelwan M, Kinkhabwala SV, Shiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007;5: 496-501.
28. Stepanova M, Aquino, Alsheddi A, Gupta R, Fang Y, Younossi ZM. Clinical predictors of fibrosis in patients with chronic liver disease. Aliment Pharmacol Ther 2010; 31:1085-94.
29. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Goodman Z, Younossi ZM. Independent predictors of fibrosis in patients with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1224-9.